NCT00853749View on ClinicalTrials.gov

Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

May 5, 2009

Primary Completion Date

December 16, 2009

Study Completion Date

December 16, 2009

Conditions
Invasive Pneumococcal Disease
Interventions
BIOLOGICAL

13-valent pneumococcal conjugate vaccine (13vPnC)

0.5 mL intramuscular injection

PROCEDURE

Blood draw

Collection of 10 mL of blood

Trial Locations (2)

101

Landspitali University Hospital, Hringbraut

109

Midstod Heilsuverndar barna, Reykjavik

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY